CADASIL Disease Discovery | MicrobiomeTrials← Back to trialsNCT02821780
CADASIL Disease Discovery
CompletedOBSERVATIONAL
Trial Details
Start: 2016-10-18Est. Completion: 2022-05-03
Enrollment target: 20 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
- Nationwide Children s Hospital, Columbus, Ohio, United States
Other microbiome trials you might be interested in
Cardiovascular DiseaseArterial StiffnessGermline Mutation in the NOTCH 3 GenePathogenesis of CADASILClinical Phenotype of CADASIL
Background:
CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy) is a ge…
Bethesda, United StatesEst. completion Jun 1, 2034